Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF9 | hg38_v1_chr14_+_24161257_24161322 | 0.43 | 1.3e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 22.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 17.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 10.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
3.0 | 8.9 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.1 | 6.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.6 | 6.2 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.9 | 5.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.5 | 4.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.0 | 4.1 | GO:1902524 | negative regulation of interferon-alpha biosynthetic process(GO:0045355) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.4 | 4.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 10.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 9.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.3 | 8.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 8.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.1 | 7.6 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 6.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 6.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 5.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 5.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.0 | 3.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 19.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 17.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.6 | 10.1 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 8.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 8.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 7.6 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.1 | 6.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 4.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.4 | 4.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.0 | 4.1 | GO:0043621 | protein self-association(GO:0043621) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 5.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 2.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 48.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.0 | 10.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 5.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 4.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 4.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 2.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |